Trial · NCT02401048
Adverse events222
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 222
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Neutropenia | Blood and lymphatic system disorders | Phase 1b/2: Follicular Lymphoma Expansion Cohort: | 6 | 27 | 13 |
| other | Neutropenia | Blood and lymphatic system disorders | Phase 1b/ 2: Diffuse Large B-cell Lymphoma Expansion Cohort: | 11 | 34 | 21 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Phase 1b/2: Follicular Lymphoma Expansion Cohort: | 4 | 27 | 4 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Phase 1b/ 2: Diffuse Large B-cell Lymphoma Expansion Cohort: | 6 | 34 | 11 |
| other | Increased tendancy to bruise | Blood and lymphatic system disorders | Phase 1b/2: Follicular Lymphoma Expansion Cohort: | 5 | 27 | 7 |
| other | Increased tendancy to bruise | Blood and lymphatic system disorders | Phase 1b/ 2: Diffuse Large B-cell Lymphoma Expansion Cohort: | 4 | 34 | 5 |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1b/2: Follicular Lymphoma Expansion Cohort: | 0 | 27 | 0 |
| other | Anaemia | Blood and lymphatic system disorders | Phase 1b/ 2: Diffuse Large B-cell Lymphoma Expansion Cohort: | 6 | 34 | 8 |
| other | Leukopenia | Blood and lymphatic system disorders | Phase 1b/2: Follicular Lymphoma Expansion Cohort: | 0 | 27 | 0 |
| other | Leukopenia | Blood and lymphatic system disorders | Phase 1b/ 2: Diffuse Large B-cell Lymphoma Expansion Cohort: | 4 | 34 | 7 |
| other | Lymphadenopathy | Blood and lymphatic system disorders | Phase 1b/2: Follicular Lymphoma Expansion Cohort: | 4 | 27 | 5 |
| other | Lymphadenopathy | Blood and lymphatic system disorders | Phase 1b/ 2: Diffuse Large B-cell Lymphoma Expansion Cohort: | 0 | 34 | 0 |
| other | Cataract | Eye disorders | Phase 1b/2: Follicular Lymphoma Expansion Cohort: | 1 | 27 | 1 |
| other | Cataract | Eye disorders | Phase 1b/ 2: Diffuse Large B-cell Lymphoma Expansion Cohort: | 3 | 34 | 3 |
| other | Dry eye | Eye disorders | Phase 1b/2: Follicular Lymphoma Expansion Cohort: | 3 | 27 | 3 |
| other | Dry eye | Eye disorders | Phase 1b/ 2: Diffuse Large B-cell Lymphoma Expansion Cohort: | 1 | 34 | 1 |
| other | Diarrhoea | Gastrointestinal disorders | Phase 1b/2: Follicular Lymphoma Expansion Cohort: | 16 | 27 | 23 |
| other | Diarrhoea | Gastrointestinal disorders | Phase 1b/ 2: Diffuse Large B-cell Lymphoma Expansion Cohort: | 16 | 34 | 27 |
| other | Nausea | Gastrointestinal disorders | Phase 1b/2: Follicular Lymphoma Expansion Cohort: | 9 | 27 | 9 |
| other | Nausea | Gastrointestinal disorders | Phase 1b/ 2: Diffuse Large B-cell Lymphoma Expansion Cohort: | 12 | 34 | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02401048/events